VIT · ASX

Vitura Health Limited (ASX:VIT)

AU$0.084

 0.0 (0.0%)
ASX:Live
15/01/2025 03:59:36 PM
HALO Ords GROWTH AUS Engulfing Bearish All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

VIT Overview

VIT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About VIT

Website

Vitura Health Limited

Telephone

61.1300.799.491

Address

Suite 8, Level 3 299 Toorak Road South Yarra, Victoria (VIC) 3141

Description

Vitura Health Ltd. engages in the sale and distribution of medicinal cannabis products and the operation of medicinal cannabis clinic businesses. It operates through the following segments: Sales and Distribution; and Clinics and Services. The Sales and Distribution segment involves in the sale and distribution of medical products including medicinal cannabis, psychedelic drugs and smoking cessation products. The Clinics and Services segment involves in the the operation of medicinal cannabis clinics and the provision of related services. The company was founded on September 27, 2018 and is headquartered in South Yarra, Australia.

VIT Price Chart

Key Stats

Market Cap

AU$48.28M

PE

6.10

EV/EBITDA

0.0

Dividends Overview

DIV Yield

5.6%

Franking

100%

Ex Dividend Date (est.)

04-Sep-23

Market Data

52 weeks range

Low 0.07 - 0.28

Trade Value (12mth)

AU$12,393.00

1 week

-3.45%

1 month

5%

YTD

2.44%

1 year

-69.45%

All time high

1.04

Key Fundamentals

EPS 3 yr Growth

77.10%

EBITDA Margin

5.30%

Operating Cashflow

$7m

Free Cash Flow Return

16.60%

ROIC

8.40%

Interest Coverage

7.50

Quick Ratio

1.10

Other Data

Shares on Issue (Fully Dilluted)

590m

HALO Sector

Healthcare

Next Company Report Date

27-Aug-25

Ex Dividend Date (est.)

04-Sep-23

Next Dividend Pay Date (est.)

28-Sep-23

Reporting Currency

AUD

Short Sell (% of issue)

0.00

VIT Announcements

Latest Announcements

Date Announcements

14 January 25

Update regarding TGA proceedings

×

Update regarding TGA proceedings

28 November 24

Final Director's Interest Notice

×

Final Director's Interest Notice

28 November 24

Final Director's Interest Notice

×

Final Director's Interest Notice

28 November 24

Final Director's Interest Notice

×

Final Director's Interest Notice

28 November 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

28 November 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

28 November 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

28 November 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

27 November 24

Presentation for 2024 AGM

×

Presentation for 2024 AGM

27 November 24

Results of 2024 Annual General Meeting

×

Results of 2024 Annual General Meeting

21 November 24

Change in substantial holding

×

Change in substantial holding

21 November 24

Proposed issue of securities - VIT

×

Proposed issue of securities - VIT

20 November 24

Application for quotation of securities - VIT

×

Application for quotation of securities - VIT

20 November 24

Cleansing Notice - section 708A(5)

×

Cleansing Notice - section 708A(5)

19 November 24

Vitura JV acquires assets of Releaf Group

×

Vitura JV acquires assets of Releaf Group

19 November 24

Proposed issue of securities - VIT

×

Proposed issue of securities - VIT

31 October 24

Notification of cessation of securities - VIT

×

Notification of cessation of securities - VIT

28 October 24

Strategy Reset delivers positive Q1 results

×

Strategy Reset delivers positive Q1 results

25 October 24

Updated Proxy Form

×

Updated Proxy Form

23 October 24

2024 Annual Report

×

2024 Annual Report

23 October 24

Board renewal and Notice of 2024 AGM

×

Board renewal and Notice of 2024 AGM

23 October 24

Shareholder statement

×

Shareholder statement

17 October 24

Vitura settles dispute with Code4 Cannabis

×

Vitura settles dispute with Code4 Cannabis

09 September 24

Appointment of Chief Technology Officer

×

Appointment of Chief Technology Officer

09 September 24

Notification of cessation of securities - VIT

×

Notification of cessation of securities - VIT

VIT Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.02 0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 257.1 99.2 -75.1 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A 9.7 6.1 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A 0.0 0.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.02 0.03 0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.03 0.01 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 355.1 12.4 -78.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 10.8 1.1 2.5 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.01 0.01 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A 0.0 -100.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A 3.5 5.6 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 80 40 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.05 0.06 0.07 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.05 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 264.8 45.6 -73.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 487 572 570 Lock Lock Lock
Basic m Lock Lock Lock Lock 482 555 570 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 67 117 124 Lock Lock Lock
     Growth % Lock Lock Lock Lock 208.5 75.2 5.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 3 6 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 13 26 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 295.5 105.9 -50.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 18.8 22.1 10.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 81 78 90 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 11 21 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 456.6 96.6 -68.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 15.8 17.8 5.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 10 20 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 483.8 100.2 -75.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 14.8 16.9 3.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 10 20 5 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 4 6 1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 6 14 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 326.7 128.3 -74.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 9.0 11.8 2.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 14 10 7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 2 -1 -13 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -2 -6 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 13 9 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1,371.4 -33.2 -24.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 16 19 11 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 43 47 71 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 5 1 9 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -11 -18 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 17 12 33 Lock Lock Lock
Equity $m Lock Lock Lock Lock 26 35 39 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 31 36 48 Lock Lock Lock
     Growth % Lock Lock Lock Lock 581.8 17.4 33.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 14.1 29.4 4.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 23.2 39.5 9.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 46.5 59.0 11.4 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 30.1 41.4 8.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 67.2 29.1 16.6 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 24.0 614.3 7.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -1.0 -0.8 -0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -42.2 -50.2 -0.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.3 3.3 1.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.9 2.7 1.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 58.3 52.4 36.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 111.0 89.3 30.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 21.6 15.5 10.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 17.1 15.3 18.6 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 4.3 4.7 16.3 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 8.8 5.9 8.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.6 2.5 1.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.6 2.5 1.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 14.5 17.1 3.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 22.7 42.8 6.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 38.3 31.4 28.8 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 14.1 29.4 4.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.6 1.3 1.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 23.2 39.5 9.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 20.0 59.8 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 4.6 23.6 9.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 21.4 23.8 19.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 16.9 23.5 34.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 38.2 47.3 53.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 20.0 25.0 30.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 18.2 22.3 23.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

04-Sep-23

DIV Yield

5.6%

Franking Level

100%

DPSg

-100.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

VIT Shortsell

Frequently Asked Questions

The current share price of Vitura Health Limited (VIT:ASX) is AU$0.084.
The 52-week high share price for Vitura Health Limited (VIT:ASX) is AU$0.28.
The 52-week low share price for Vitura Health Limited (VIT:ASX)? is AU$0.07.
The current TTM dividend payout for Vitura Health Limited (VIT:ASX) is 5.60.
The last dividend payment of Vitura Health Limited (VIT:ASX) is AU$0.01.
Vitura Health Limited (VIT:ASX) has a franking level of 100.0%.
Vitura Health Limited (VIT:ASX) is classified in the Healthcare.
The current P/E ratio for Vitura Health Limited (VIT:ASX) is 6.10.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.